Previous studies have reported expression levels of BIRC5 (Jin et al., 2015), KITLG (Hu et al., 2021), SPP1 (Long et al., 2018), and SHC1 (He et al., 2019) could serve as biomarkers for predicting prognosis in HCC. This evidence concerns the gene SHC1 and hepatocellular carcinoma.